Validation and evaluation of fecal calprotectin assays in pediatric inflammatory bowel disease
β Scribed by Kittanakom, Saranya; Sharif Shajib, Md.; Hinzmann, Celynne; Garvie, Kristine; Turner, Joceline; Brooks, Dan; Odeh, Sufian; Issenman, Robert; Chetty, V. Tony; Macri, Joseph; Khan, Waliul
- Book ID
- 125860609
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 179 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0009-9120
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: Fecal calprotectin (FC) has been proposed as a noninvasive surrogate marker to determine the degree of intestinal inflammation and predicting relapse in patients with inflammatory bowel disease (IBD). The aim was to compare FC levels in IBD and healthy controls, to correlate FC levels wi
## Background: Fecal calprotectin is a sensitive marker for gut inflammation. recently, we have established that a related protein, s100a12, is elevated in the feces of children with inflammatory bowel disease (ibd). this may represent a specific and sensitive disease marker. the objective was to i
## Background: The purpose of the study was to determine the role of fecal calprotectin and lactoferrin in the prediction of inflammatory bowel disease relapses, both in patients with ulcerative colitis (uc) and crohn's disease (cd), in a large, long-term, follow-up study. ## Methods: The prospec